Medtronic (MDT) PT Raised to $83 at Piper Jaffray Following Q2 and Deal Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Medtronic (MDT) Reports In-Line Q2 EPS; Updates on FY15 Outlook
November 18, 2014 7:19 AM ESTMedtronic (NYSE: MDT) reported Q2 EPS of $0.96, in-line with the analyst estimate of $0.96. Revenue for the quarter came in at $4.4 million versus the consensus estimate of $4.37 million.
The company today updated its revenue growth outlook and reiterated its diluted non-GAAP earnings per share... More
